Welcome to LookChem.com Sign In|Join Free
  • or
Benzene, 1-[1-methyl-1-(methylsulfonyl)ethyl]-4-nitro- is a chemical with a specific purpose. Lookchem provides you with multiple data and supplier information of this chemical.

635702-62-4

Post Buying Request

635702-62-4 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

635702-62-4 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 635702-62-4 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 6,3,5,7,0 and 2 respectively; the second part has 2 digits, 6 and 2 respectively.
Calculate Digit Verification of CAS Registry Number 635702-62:
(8*6)+(7*3)+(6*5)+(5*7)+(4*0)+(3*2)+(2*6)+(1*2)=154
154 % 10 = 4
So 635702-62-4 is a valid CAS Registry Number.

635702-62-4Downstream Products

635702-62-4Relevant academic research and scientific papers

Treatment Method

-

Page/Page column 12, (2009/01/20)

The present invention is directed to methods of treating an ocular neovascular disorder in a mammal by administration of pyrimidine derivatives, benzodiazepinyl derivatives and pharmaceutical compositions containing the same. The invention encompasses methods of treating an ocular neovascular disorder by administration of 5-[[4-[(2,3-Dimethyl-2H-indazol-6-yl)methylamino]-2-pyrimidinyl]amino]-2-methylbenzenesulfonamide, (S)-3-oxo-8-[3-(pyridin-2-ylamino)-1-propyloxy]-2-(2,2,2-trifluoroethyl)-2,3,4,5-tetrahydro-1H-2-benzazepine-4-acetic acid or salts or solvates thereof. Combination therapies for the treatment of ocular neovascular disorders are also encompassed.

CANCER TREATMENT METHOD

-

Page/Page column 38, (2010/02/14)

A method of treating cancer is described including administration of a pyrimidine derivative and a quinazoline derivative as well as a pharmaceutical composition including the same.

CHEMICAL PROCESS

-

Page 51-52, (2010/02/04)

A process for the preparation of pyrimidine derivatives, which are useful as VEGFR2 inhibitors is described herein. The described invention also includes pyrimidine derivatives as well as methods of using the same in the treatment of hyperproliferative diseases.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 635702-62-4